CDK1 and uterine carcinosarcoma: CDK1 genetic alterations in various tumors in the TCGA database were identified and are summarized in Figure 1A. The highest frequency of CDK1 genetic alteration (7.02%) was observed in patients with uterine carcinosarcoma, with amplification as the primary genetic alteration.